Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Lymphoid 112Other hematologic neoplasm 92Myeloid 41Plasma cell 32Sarcoma 21Classical hematology 21Dermatologic 15Genitourinary 11CNS 9Thoracic 5Gynecologic 5Breast 4Other neoplasm 2Head & Neck 2Gastrointestinal 2Tumor-Agnostic 1Other solid neoplasm 1

Conditions

Carcinoma, Hepatocellular 2

Interventions

Oxaliplatin 1409Fluorouracil 1298Capecitabine 1085Gemcitabine 1042Leucovorin 928Irinotecan 815Bevacizumab 803Cisplatin 666Radiotherapy 535Cetuximab 469pembrolizumab 428Paclitaxel 389Nivolumab 336130-nm albumin-bound paclitaxel 322Drug Therapy 314Docetaxel 286S 1 (combination) 273Sorafenib 266Folfox protocol 261Albumin-Bound Paclitaxel 259sintilimab 211durvalumab 209Surgical Procedures, Operative 203tislelizumab 202Radiosurgery 202lenvatinib 201apatinib 198Carboplatin 186Magnetic Resonance Spectroscopy 181regorafenib 180

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Methylprednisolone × Gastrointestinal × Clear all
NCT01726465 2013-11-13

MENHIR

Istituto Clinico Humanitas

Phase 2 Terminated
50 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT01137084 2010-06-04

Liver Transplantation Results in Hepatocellular Carcinoma Patients With Immunosuppression Without Steroids

Shanghai Jiao Tong University School of Medicine

Phase NA Completed
300 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡